Hydroxychloroquin

A variation on this theme consists in first displacement of the chlorine in 73 with ethylaminoethanol. Reductive amination of the ketone by means of ammonia in the presence of hydrogen gives the hydroxylated diamine (77). Use of this intermediate to effect displacement of the halogen at the 4 position of 70 affords hydroxychloroquine (78). ... 

Hydroxychloroquine sulfate m-Chloroperbenzoic acid Alfacalcidol Minoxidil... 

N-Ethy I-N-2-hydroxy ethylamine Hydroxychloroquine sulfate Ethyl a-hydroxyisobutyrate Trimethadione Ethyl iodide... 

The adverse reactions associated witii die administration of chloroquine (Aralen HC1 and phosphate) and hydroxychloroquine include hypotension, electrocardiographic changes, visual disturbances, headache, nausea, vomiting, anorexia, diarrhea, and abdominal cramps. 

Hydroxychloroquine 0.4 g is ordered. The drug is available in 200-mg tablets. The nurse administers... 

The miscellaneous drugp are used to treat a variety of musculoskeletal disorders. Ffenicillamine, methotrexate (MTX), and hydroxychloroquine are used to treat rheumatoid arthritis in patients who have had an insufficient therapeutic response to or are intolerant of other antirheumatic drugp such as the sailcylates and NSAIDs. The Summary Drug Table Drug s Used to Tream Musculoskeletal Disorders provides additional information about these and other drug s. One compound, hylan G-F 20, listed in the Summary Drug Table is not used for rheumatoid arthritis, but rather, for osteoarthritis knee pain. It is a viscous, elastic... 

The mechanism of action of penicillamine, MTX, and hydroxychloroquine in the treatment of rheumatoid arthritis is unknown. 

Hydroxychloroquine administration may result in irritability, nervousness, anorexia, nausea, vomiting, and diarrhea This drug also may have adverse effects on the eye, including blurred vision, comeal edema, halos around lights, and retinal damage. Hematologic effects, such as aplastic anemia and leukopenia, may also be seen. 

These dru are contraindicated in patients with known hypersensitivity. Hydroxychloroquine is contraindicated in patients with porphyria (a group of serious inherited disorders affecting the bone marrow or the liver), psoriasis (chronic skin disorder), and retinal disease (may cause irreversible retinal damage). MTX is contraindicated during pregnancy because it is a Pregnancy Category X dmg and may cause birth defects... 

MISCELLANEOUS DRUGS. The nurse administers hydroxychloroquine with food or milk to help prevent... 

MTX is potentially toxic. Therefore, the nurse observes closely for development of adverse reactions, such as thrombocytopenia (see Nursing Alert in Gold Compounds section) and leukopenia (see discussion of adverse reactions associated with hydroxychloroquine). Hematology, liver, and renal function studies are monitored every 1 to 3 months with MTX therapy. The primary care provider is notified of abnormal hematology, liver function, or kidney function finding. The nurse immediately brings all adverse reactions or suspected adverse reactions to the attention of the primary health care provider. 

C5H9CIO 5891-21-4) see Hydroxychloroquine 5-chloropentanoyI chloride (C5Hj Cl20 1575-61-7) see Cilostazol JV-(S-chloropentanoyl)cyclohexylamine (C11H20CINO 15865-18-6) see Cilostazol... 

C4H,N0 110-73-6) see BamifyUine Hydroxychloroquine ethyl p-amino-P-ethoxy aery late (C7H13NO3 39632-87-6) see Muzolimine ethyl 7-aminoheptanoate... 

Benzocaine, P-lactams, chloramphenicol, chloroquine, dapsone, hydroxychloroquine, methylene blue, nitrofurantoin, phenazopy-ridine, rasburicase, and sulfonamide antimicrobials... 

Hydroxychloroquine 200 mg bid Oral 8-24 weeks N, D, HA, vision changes, skin pigmentation Eye exam every 12 mo. ... 

In addition to relying on safety and efficacy data, the initial DMARD choice depends on disease severity, patient characteristics (i.e., comorbidities, likelihood of adherence), cost, and clinician experience with the medication.1,7 Methotrexate alone or in combination therapy is the initial treatment of choice for patients with aggressive disease. Patients with early, mild disease may receive monotherapy with sulfasalazine or hydroxychloroquine. Agents such as azathioprine, D-penicillamine, and gold salts are used rarely today because of concerns about toxicity and reduced efficacy.1,15... 

The exact mechanism of action of these drugs is unknown, but both agents are fairly well tolerated. Hydroxychloroquine or sulfasalazine may be initiated on diagnosis of mild disease. Owing to their slow onset of action, each drug must be given at... 

---